Skip to Main Content

Paper Details

CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer.
Nat Commun
29
2021
21 locus, 260 rCREs, 3D genome, 8q24, CTCF, CTCF binding site, H3K27ac, MYC, MYC eQTL, MYC promoter, PCa, PCa cell, PCa cell lines, PVT1, Prostate cancer, cell, cell-line-specific essential rCREs, noncoding cis-regulatory elements, prostate, prostate cancer, rCRE, rCREs, risk, risk SNP, rs11986220
Animals, CCCTC-Binding Factor, CRISPR-Cas Systems, Carcinogenesis, Cell Line, Tumor, DNA Methylation, Gene Editing, Genetic Predisposition to Disease, Genome-Wide Association Study, Humans, Male, Mice, Inbred NOD, Mice, SCID, Polymorphism, Single Nucleotide, Promoter Regions, Genetic, Prostatic Neoplasms, Proto-Oncogene Proteins c-myc, Quantitative Trait Loci, Regulatory Elements, Transcriptional, Risk Factors
Author NameAffiliation
Musaddeque AhmedPrincess Margaret Cancer Center/University Health Network
Fraser SoaresPrincess Margaret Cancer Center/University Health Network
Jihan XiaUniversity of Oulu
Yue YangChanghai Hospital
Jing LiChanghai Hospital
Haiyang GuoPrincess Margaret Cancer Center/University Health Network
Peiran SuPrincess Margaret Cancer Center/University Health Network
Peiran SuUniversity of Toronto
Yijun TianH. Lee Moffitt Cancer Center and Research Institute
Hyung Joo LeeWashington University in St. Louis
Miranda WangPrincess Margaret Cancer Center/University Health Network
Naznin AkhtarPrincess Margaret Cancer Center/University Health Network
Kathleen E HoulahanUniversity of Toronto
Kathleen E HoulahanOntario Institute for Cancer Research
Kathleen E HoulahanVector Institute
Kathleen E HoulahanDavid Geffen School of Medicine, University of California los angeles
Almudena BoschDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Almudena BoschIcahn School of Medicine at Mount Sinai
Stanley ZhouPrincess Margaret Cancer Center/University Health Network
Stanley ZhouUniversity of Toronto
Parisa MazrooeiPrincess Margaret Cancer Center/University Health Network
Parisa MazrooeiUniversity of Toronto
Junjie T HuaPrincess Margaret Cancer Center/University Health Network
Junjie T HuaUniversity of Toronto
Sujun ChenPrincess Margaret Cancer Center/University Health Network
Sujun ChenUniversity of Toronto
Sujun ChenOntario Institute for Cancer Research
Jessica PetriccaPrincess Margaret Cancer Center/University Health Network
Jessica PetriccaUniversity of Toronto
Yong ZengPrincess Margaret Cancer Center/University Health Network
Alastair DaviesVancouver General Hospital and Department of Urologic Sciences, The University of British Columbia
Michael FraserPrincess Margaret Cancer Center/University Health Network
Michael FraserOntario Institute for Cancer Research
David A QuigleyHelen Diller Family Comprehensive Cancer Center, University of California at San Francisco
David A QuigleyUniversity of California at San Francisco
Felix Y FengHelen Diller Family Comprehensive Cancer Center, University of California at San Francisco
Felix Y FengUniversity of California at San Francisco
Felix Y FengUniversity of California at San Francisco
Felix Y FengUniversity of California at San Francisco
Paul C BoutrosVector Institute
Paul C BoutrosDavid Geffen School of Medicine, University of California los angeles
Paul C BoutrosUniversity of California los angeles
Paul C BoutrosJonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California los angeles
Paul C BoutrosInstitute for Precision Health, University of California los angeles
Mathieu LupienPrincess Margaret Cancer Center/University Health Network
Mathieu LupienUniversity of Toronto
Mathieu LupienOntario Institute for Cancer Research
Amina ZoubeidiVancouver General Hospital and Department of Urologic Sciences, The University of British Columbia
Liang WangH. Lee Moffitt Cancer Center and Research Institute
Martin J WalshDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
  • 1 - 50

Datasets